Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells
- PMID: 21993621
- PMCID: PMC3198846
- DOI: 10.1038/nature10424
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells
Abstract
Human induced pluripotent stem cells (iPSCs) represent a unique opportunity for regenerative medicine because they offer the prospect of generating unlimited quantities of cells for autologous transplantation, with potential application in treatments for a broad range of disorders. However, the use of human iPSCs in the context of genetically inherited human disease will require the correction of disease-causing mutations in a manner that is fully compatible with clinical applications. The methods currently available, such as homologous recombination, lack the necessary efficiency and also leave residual sequences in the targeted genome. Therefore, the development of new approaches to edit the mammalian genome is a prerequisite to delivering the clinical promise of human iPSCs. Here we show that a combination of zinc finger nucleases (ZFNs) and piggyBac technology in human iPSCs can achieve biallelic correction of a point mutation (Glu342Lys) in the α(1)-antitrypsin (A1AT, also known as SERPINA1) gene that is responsible for α(1)-antitrypsin deficiency. Genetic correction of human iPSCs restored the structure and function of A1AT in subsequently derived liver cells in vitro and in vivo. This approach is significantly more efficient than any other gene-targeting technology that is currently available and crucially prevents contamination of the host genome with residual non-human sequences. Our results provide the first proof of principle, to our knowledge, for the potential of combining human iPSCs with genetic correction to generate clinically relevant cells for autologous cell-based therapies.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3198846/bin/ukmss-36204-f0001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3198846/bin/ukmss-36204-f0002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3198846/bin/ukmss-36204-f0003.gif)
Comment in
-
A ZFN/piggyBac step closer to autologous liver cell therapy.Hepatology. 2012 Jun;55(6):2033-5. doi: 10.1002/hep.25715. Hepatology. 2012. PMID: 22422378 No abstract available.
Similar articles
-
Sustained knockdown of a disease-causing gene in patient-specific induced pluripotent stem cells using lentiviral vector-based gene therapy.Stem Cells Transl Med. 2013 Sep;2(9):641-54. doi: 10.5966/sctm.2013-0017. Epub 2013 Aug 7. Stem Cells Transl Med. 2013. PMID: 23926210 Free PMC article.
-
hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in α1-antitrypsin deficiency.J Hepatol. 2018 Oct;69(4):851-860. doi: 10.1016/j.jhep.2018.05.028. Epub 2018 Jun 5. J Hepatol. 2018. PMID: 29879455 Free PMC article.
-
Adenine base editing reduces misfolded protein accumulation and toxicity in alpha-1 antitrypsin deficient patient iPSC-hepatocytes.Mol Ther. 2021 Nov 3;29(11):3219-3229. doi: 10.1016/j.ymthe.2021.06.021. Epub 2021 Jul 2. Mol Ther. 2021. PMID: 34217893 Free PMC article.
-
Gene correction in patient-specific iPSCs for therapy development and disease modeling.Hum Genet. 2016 Sep;135(9):1041-58. doi: 10.1007/s00439-016-1691-5. Epub 2016 Jun 2. Hum Genet. 2016. PMID: 27256364 Free PMC article. Review.
-
Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.J Inherit Metab Dis. 2008 Feb;31(1):21-34. doi: 10.1007/s10545-007-0748-y. Epub 2008 Jan 16. J Inherit Metab Dis. 2008. PMID: 18193338 Review.
Cited by
-
Bioengineered Organoids Offer New Possibilities for Liver Cancer Studies: A Review of Key Milestones and Challenges.Bioengineering (Basel). 2024 Apr 1;11(4):346. doi: 10.3390/bioengineering11040346. Bioengineering (Basel). 2024. PMID: 38671768 Free PMC article. Review.
-
Computational Tools to Assist in Analyzing Effects of the SERPINA1 Gene Variation on Alpha-1 Antitrypsin (AAT).Genes (Basel). 2024 Mar 6;15(3):340. doi: 10.3390/genes15030340. Genes (Basel). 2024. PMID: 38540399 Free PMC article. Review.
-
Precise genetic engineering with piggyBac transposon in plants.Plant Biotechnol (Tokyo). 2023 Dec 25;40(4):255-262. doi: 10.5511/plantbiotechnology.23.0525a. Plant Biotechnol (Tokyo). 2023. PMID: 38434112 Free PMC article.
-
Stem cell modeling of nervous system tumors.Dis Model Mech. 2024 Feb 1;17(2):dmm050533. doi: 10.1242/dmm.050533. Epub 2024 Feb 14. Dis Model Mech. 2024. PMID: 38353122 Free PMC article. Review.
-
Efficient gene editing in induced pluripotent stem cells enabled by an inducible adenine base editor with tunable expression.Sci Rep. 2023 Dec 11;13(1):21953. doi: 10.1038/s41598-023-42174-2. Sci Rep. 2023. PMID: 38081875 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous